SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-244238
Filing Date
2017-08-01
Accepted
2017-08-01 16:06:05
Documents
5
Period of Report
2017-08-01
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d428284d8k.htm 8-K 23193
2 EX-3.1 d428284dex31.htm EX-3.1 24917
3 EX-3.2 d428284dex32.htm EX-3.2 153560
4 EX-99.1 d428284dex991.htm EX-99.1 6543
5 GRAPHIC g428284g97o62.jpg GRAPHIC 3966
  Complete submission text file 0001193125-17-244238.txt   215118
Mailing Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362
Business Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362 (818) 629-2256
Sienna Biopharmaceuticals, Inc. (Filer) CIK: 0001656328 (see all company filings)

IRS No.: 273364627 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38155 | Film No.: 17996777
SIC: 2834 Pharmaceutical Preparations